Article info

Protocol
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial

Authors

  1. Correspondence to Dr Visalini Nair-Shalliker; visalinin{at}nswcc.org.au
View Full Text

Citation

Nair-Shalliker V, Smith DP, Gebski V, et al
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial

Publication history

  • Received August 24, 2020
  • Revised December 16, 2020
  • Accepted January 4, 2021
  • First published March 2, 2021.
Online issue publication 
March 02, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.